Welcome to the healthcare professionals section

In this section you will find information on the product TendoVis™ and its use in the treatment of epicondylitis. We have included TendoVis™ prescribing information, clinical references, and other useful information.

If you require further assistance, please contact us.


Reduces time to recovery

A clinical study against placebo have shown that patients in the TendoVis™ were able to return to sports within 18 (±11) days. This was not seen in the control group.

Clinical results:

Increased grip strength

Lesser pain when gripping

Lesser pain at rest

If you want to have more information, please click here

Improvement in the quality of healing

By interacting with the collagen fibres in the tendon, biocompatible TendoVis™ facilitates the fibres into their normal parallel alignment for faster healing. TendoVis™ also acts as a structural support and lubricant at the injury site to improve the healing process.

Manage pain with a very low probability of systemic side effects

Hyaluronic Acid, also known as sodium hyaluronate, has an ancillary effect of reducing pain. TendoVis™ containing STABHA™ (Soft Tissue Adapted BIOCOMPATIBLE Hyaluronic Acid) will help reduce the pain in epicondylitis due to these ancillary effects with low probability of systemic side effects (none experienced during clinical trial and since the start of marketing globally).

Manage pain and swelling with very low probability of systemic side effects

Hyaluronic acid has an ancillary effect of reducing pain and limit inflammation. TendoVis™ containing STABHA™ will help reduce the pain and limit inflammation in an ankle sprain due to these ancillary effects with low probability of systemic side effects (none experienced during clinical trials until now).

TendoVis™ and Standard of Care

TendoVis™ is a peri-articular injection that can only be performed by a medical professional that has been trained in the injection technique. TendoVis™ should be injected into the injury site and the 2nd injection to be administered 1 week after the 1st injection.

TendoVis™ was designed to be used concomitantly with the standard of care - rest, ice and compression. Using TendoVis™ together with the standard of care will allow the patient to regain mobility and experience less pain faster.

How TendoVis™ works?

TendoVis™ containing STABHA™ (Soft Tissue Adapted
B
iocompatible Hyaluronic Acid) has been designed specifically to interact optimally with soft tissue ligaments and tendons due to its purity profile and biocompatibility. When STABHA™ is injected into the site of injury, it reacts rapidly and efficiently with the microtears in the tendon. STABHA™ acts thanks to a dynamic supporting feature as it helps align the collagen fibres and restores the morphological and functional characteristic of the tendon structure. STABHA™ also helps by providing the ECM (Extra Cellular Matrix) with the required Hyaluronic Acid to aid in healing.

By saturating the injury site with STABHA™, the full potential of its supportive role is achieved.

About TendoVis™

The main content of TendoVis™ is STABHA™ (Soft Tissue Adapted
B
iocompatible Hyaluronic Acid).

TendoVis™ is a registered product with the CE mark and both TendoVis™ and the manufacturing process for STABHA™ are patented.

TendoVis™ is used for treating tennis elbow / epicondylitis as well as grades 1 and 2 ankle sprains. It is administered via a peri-articular injection into the site of injury using the fanning technique. The fanning technique helps to spread TendoVis™ over a large surface area within the injury site to have optimal interactions with the microtears in tendons and torn ligaments.